• Jochen Hinkelbein, Jan Schmitz, Massimo Lamperti, and Thomas Fuchs-Buder.
• Department of Anesthesiology and Intensive Care Medicine, University Hospital of Cologne, Cologne, Germany.
• Curr Opin Anaesthesiol. 2020 Aug 1; 33 (4): 533-538.

Purpose Of ReviewThe present review provides an overview of the different fields of procedural sedation and analgesia (PSA), describing the evidence from recently published studies concerning anxiety and moderate pain, cardiac interventions, gastrointestinal interventions, and PSA use in infants. It also provides guidance for practitioners of both unscheduled and scheduled procedural sedation, and a summary of the current guideline for PSA.Recent FindingsSafety always has to be first priority. Recently published literature is focusing on the combination of different well established drugs such as dexmedetomidine, remifentanil, propofol, and ketamine. These traditional and well known drugs are commonly used for PSA. The combinational use of multiple drugs seems to have benefits for both the provider and patient. Furthermore, there is growing interest into specific protocols and adaption for special circumstances. The preferred medications used for PSA should be both effective and well tolerated.SummaryProcedural sedation deserves to have high degree of attention for potential adverse events. New combinations of well established drugs provide a better pharmacokinetic profile, fit to different indications and offer multiple benefits for both provider and patient.

13 keywords...

hide…